Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer Artificial intelligence (AI) ...
Actualmente se muestran resultados que pueden ser inaccesibles para usted.
Ocultar resultados inaccesibles
